Setting Sustainability Goals with Pierre Luzeau (DCAT 2023)
Pierre Luzeau, CEO of Seqens, discusses Seqen's commitment to sustainability and how one can work toward it within their own company.
As part of ongoing coverage of DCAT, the PharmTech editors touched base with Pierre Luzeau, CEO of Seqens. In in our discussion, Pierre discussed various aspects of sustainability, including:
- The extensive measures his company has put in place to committ to sustainability
- Underappreciated practices and techniques that contribute to sustainability
- Why sustainability will be so pivotal for biopharma companies over the course of the next ten years.
For more of our coverage on DCAT in 2023, viewers can visit this page.
Recent Videos
Related Content
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma
February 14th 2025Article
The approval of an ADCETRIS combination regimen is based on positive data from a Phase III trial where the combination regimen demonstrated a clinically meaningful reduction in the risk of death.
